Theracarb Inc

TheraCarb Inc. is a private, early-stage biopharmaceutical company developing medicines for the treatment of infectious diseases. With vaccine products and drug platform-technologies TheraCarb is focused on pre-clinical and early-stage clinical studies and partnerships for developing late-stage products and marketing. TheraCarb’s pipeline includes vaccine candidates for Candida albicans and therapeutic drugs for E. coli and cholera. TheraCarb is a spin-off from the Alberta Ingenuity Centre for Carbohydrate Science and is the Centre’s preferred vehicle for commercialization of its technologies in the field of therapeutics and vaccines for infectious diseases.